GreenBone Ortho

GreenBone Ortho is a private, commercial-stage medical device company pioneering a novel biomaterial for bone regeneration. Its core technology transforms the natural microstructure of rattan wood into an inorganic, biomimetic hydroxyapatite scaffold that mimics human cancellous bone. With its CE-marked product b.Bone already on the market and supported by clinical evidence, the company is targeting a significant global opportunity in the bone graft substitute market. Key investors include 3B Future Health Fund, Innogest SGR, and CDP Venture Capital, providing financial backing for its commercial expansion and R&D.

Proprietary multi-step process that transforms the natural microstructure of rattan wood into an inorganic, biomimetic hydroxyapatite scaffold that mimics human cancellous bone for use as a bone graft substitute.

GreenBone competes in the synthetic bone graft substitute market against large medtech players (e.g., Stryker, Zimmer Biomet) and other ceramic/polymer-based products. Its primary differentiation is its truly biomimetic 3D structure derived from rattan wood, which may offer superior osteointegration compared to more conventional synthetic granules or blocks.